New asthma drug aims to heal damaged airways
NCT ID NCT03953300
Summary
This study is testing whether the drug benralizumab can reduce inflammation and improve the physical structure of the lungs in people with a severe type of asthma. It involves 75 adults whose asthma is not well-controlled despite using standard high-dose inhalers. Researchers will compare the drug to a placebo over 48 weeks, using lung scans and tissue samples to see if it helps repair the airways.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Birmingham, Alabama, 35209, United States
-
Research Site
Los Angeles, California, 90033, United States
-
Research Site
Jacksonville, Florida, 32204, United States
-
Research Site
Miami, Florida, 33166, United States
-
Research Site
Snellville, Georgia, 30078, United States
-
Research Site
Indianapolis, Indiana, 46268, United States
-
Research Site
Iowa City, Iowa, 52242, United States
-
Research Site
Kansas City, Kansas, 66160, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Bloomfield Hills, Michigan, 48301, United States
-
Research Site
Rochester, Minnesota, 55905, United States
-
Research Site
St Louis, Missouri, 63156, United States
-
Research Site
Maspeth, New York, 11378, United States
-
Research Site
New Bern, North Carolina, 28562, United States
-
Research Site
Winston-Salem, North Carolina, 27104, United States
-
Research Site
Pittsburgh, Pennsylvania, 15213, United States
-
Research Site
Galveston, Texas, 77555, United States
-
Research Site
Lewisville, Texas, 75067, United States
-
Research Site
Mansfield, Texas, 76063, United States
-
Research Site
Calgary, Alberta, T2N 4Z6, Canada
-
Research Site
Aalborg, 9000, Denmark
-
Research Site
Aarhus N, 8200, Denmark
-
Research Site
Copenhagen, 2400, Denmark
-
Research Site
Hvidovre, 2650, Denmark
-
Research Site
Næstved, 4700, Denmark
-
Research Site
Odense C, 5000, Denmark
-
Research Site
Vejle, 7100, Denmark
-
Research Site
Gothenburg, 413 45, Sweden
-
Research Site
Lund, 22185, Sweden
-
Research Site
Cambridge, CB2 2QQ, United Kingdom
-
Research Site
Headington, OX3 9DU, United Kingdom
-
Research Site
Leicester, LE3 9QP, United Kingdom
-
Research Site
Liverpool, L7 8XP, United Kingdom
-
Research Site
London, W1G 8HU, United Kingdom
-
Research Site
Wythenshawe, M23 9LT, United Kingdom
Conditions
Explore the condition pages connected to this study.